SWAV RSI Chart
Last 7 days
0.2%
Last 30 days
1%
Last 90 days
41.5%
Trailing 12 Months
14.3%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 788.0M | 0 | 0 | 0 |
2023 | 557.2M | 616.6M | 671.3M | 730.2M |
2022 | 298.9M | 363.7M | 429.9M | 489.7M |
2021 | 84.5M | 130.1M | 175.7M | 237.1M |
2020 | 50.9M | 51.1M | 59.4M | 67.8M |
2019 | 18.2M | 25.9M | 33.7M | 42.9M |
2018 | 4.4M | 7.0M | 9.6M | 12.3M |
2017 | 0 | 0 | 0 | 1.7M |
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index
Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>
Returns of $10,000 invested in:
Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224
Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
May 02, 2024 | godshall douglas evan | sold (taxes) | -377,303 | 329 | -1,144 | president & ceo |
May 02, 2024 | phung trinh | sold (taxes) | -108,178 | 329 | -328 | vp, finance |
May 02, 2024 | zacharias isaac | sold (taxes) | -174,799 | 329 | -530 | president, cco |
Mar 26, 2024 | francis laura | sold | -450,000 | 300 | -1,500 | - |
Mar 26, 2024 | francis laura | acquired | 9,882 | 6.588 | 1,500 | - |
Mar 26, 2024 | zacharias isaac | sold | -1,150,680 | 287 | -4,000 | president, cco |
Mar 26, 2024 | francis laura | gifted | - | - | -1,500 | - |
Mar 26, 2024 | francis laura | gifted | - | - | 1,500 | - |
Mar 11, 2024 | zacharias isaac | sold (taxes) | -138,633 | 250 | -554 | president, cco |
Mar 06, 2024 | phung trinh | sold | -5,315 | 253 | -21.00 | vp, finance |
Which funds bought or sold SWAV recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 08, 2024 | Fortis Capital Advisors, LLC | new | - | 275,157 | 275,157 | 0.12% |
May 08, 2024 | US BANCORP \DE\ | added | 53.89 | 303,707 | 490,074 | -% |
May 08, 2024 | Sandy Spring Bank | new | - | 16,282 | 16,282 | -% |
May 08, 2024 | Jackson Square Partners, LLC | reduced | -16.11 | 23,312,800 | 77,078,900 | 3.21% |
May 08, 2024 | Camelot Portfolios, LLC | sold off | -100 | -243,335 | - | -% |
May 08, 2024 | Cetera Trust Company, N.A | added | 25.00 | 173,182 | 325,630 | 0.20% |
May 08, 2024 | GREAT LAKES ADVISORS, LLC | new | - | 704,338 | 704,338 | 0.01% |
May 08, 2024 | Bell Investment Advisors, Inc | added | 16.00 | 4,680 | 9,444 | -% |
May 08, 2024 | TD Asset Management Inc | reduced | -24.94 | 4,490,780 | 20,376,600 | 0.02% |
May 08, 2024 | ProShare Advisors LLC | reduced | -7.43 | 223,727 | 608,277 | -% |
Unveiling Shockwave Medical Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Shockwave Medical Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABT | 182.1B | 40.3B | 32.37 | 4.52 | ||||
BDX | 67.9B | 19.7B | 50.95 | 3.44 | ||||
ALGN | 21.1B | 3.9B | 45.69 | 5.39 | ||||
BAX | 18.3B | 14.9B | 6.92 | 1.23 | ||||
MID-CAP | ||||||||
ATR | 9.9B | 3.5B | 31.58 | 2.79 | ||||
HSIC | 9.4B | 12.5B | 24.22 | 0.75 | ||||
BIO | 7.9B | 2.6B | -24.54 | 3.04 | ||||
XRAY | 5.9B | 3.9B | -62.67 | 1.49 | ||||
AXNX | 3.4B | 387.1M | -215.82 | 8.88 | ||||
PDCO | 2.4B | 6.6B | 12.18 | 0.36 | ||||
SMALL-CAP | ||||||||
AHCO | 1.2B | 3.2B | -1.76 | 0.38 | ||||
ANIK | 374.6M | 169.3M | -4.88 | 2.21 | ||||
ANGO | 245.1M | 324.0M | -1.27 | 0.76 | ||||
APYX | 57.5M | 50.5M | -2.52 | 1.14 | ||||
AEMD | 3.1M | 3.7M | -0.25 | 0.82 |
Shockwave Medical Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | 7.8% | 219 | 203 | 186 | 180 | 161 | 144 | 131 | 121 | 94.00 | 84.00 | 65.00 | 56.00 | 32.00 | 23.00 | 20.00 | 10.00 | 15.00 | 14.00 | 11.00 | 10.00 | 7.00 |
Gross Profit | 7.3% | 191 | 178 | 162 | 156 | 140 | 127 | 113 | 104 | 81.00 | 72.00 | 54.00 | 46.00 | 24.00 | 16.00 | 14.00 | 7.00 | 10.00 | 9.00 | 7.00 | 6.00 | 4.00 |
Costs and Expenses | 10.3% | 148 | 134 | 118 | 123 | 100 | 84.00 | 77.00 | 74.00 | 65.00 | 58.00 | 51.00 | 46.00 | 41.00 | 32.00 | 27.00 | 25.00 | 29.00 | 13.00 | 24.00 | 21.00 | 19.00 |
Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 27.00 | 25.00 | 29.00 | - | 20.00 | 17.00 | 16.00 |
S&GA Expenses | 10.9% | 74.00 | 67.00 | 57.00 | 57.00 | 54.00 | 43.00 | 42.00 | 41.00 | 36.00 | 33.00 | 28.00 | 26.00 | 24.00 | 16.00 | 14.00 | 11.00 | 10.00 | 10.00 | 8.00 | 7.00 | 6.00 |
R&D Expenses | 5.1% | 44.00 | 42.00 | 40.00 | 37.00 | 27.00 | 24.00 | 20.00 | 21.00 | 17.00 | 15.00 | 14.00 | 12.00 | 10.00 | 9.00 | 8.00 | 8.00 | 12.00 | 10.00 | 8.00 | 7.00 | 7.00 |
EBITDA Margin | -1.1% | 0.26* | 0.26* | 0.26* | 0.26* | 0.28* | 0.26* | 0.22* | 0.17* | 0.11* | -0.02* | -0.19* | -0.38* | - | - | - | - | - | - | - | - | - |
Interest Expenses | -0.2% | 3.00 | 3.00 | 3.00 | 1.00 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income Taxes | -147.4% | -5.30 | 11.00 | 10.00 | 4.00 | 2.00 | -96.26 | 0.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Before Taxes | -9.8% | 50.00 | 55.00 | 45.00 | 33.00 | 41.00 | 45.00 | 35.00 | 26.00 | 15.00 | 13.00 | 2.00 | -0.35 | -23.56 | -15.87 | -12.90 | -18.10 | -18.75 | -14.73 | -12.93 | -10.59 | -12.79 |
EBT Margin | -2.4% | 0.23* | 0.24* | 0.24* | 0.25* | 0.26* | 0.25* | 0.21* | 0.15* | 0.10* | -0.04* | -0.21* | -0.40* | - | - | - | - | - | - | - | - | - |
Net Income | 24.9% | 55.00 | 44.00 | 35.00 | 29.00 | 39.00 | 141 | 35.00 | 26.00 | 15.00 | 13.00 | 2.00 | -0.42 | -23.60 | -15.87 | -12.93 | -18.12 | -18.77 | -14.74 | -12.96 | -10.61 | -12.80 |
Net Income Margin | 2.9% | 0.21* | 0.20* | 0.36* | 0.40* | 0.43* | 0.44* | 0.20* | 0.15* | 0.10* | -0.04* | -0.22* | -0.41* | - | - | - | - | - | - | - | - | - |
Free Cashflow | -56.8% | 27.00 | 64.00 | 44.00 | 31.00 | 27.00 | 41.00 | 27.00 | 25.00 | -1.35 | 18.00 | 6.00 | -0.52 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | 4.9% | 1,644 | 1,567 | 1,474 | 787 | 783 | 646 | 476 | 417 | 373 | 346 | 299 | 276 | 269 | 272 | 281 | 287 | 221 | 232 | 138 | 147 | 158 |
Current Assets | 4.1% | 1,275 | 1,225 | 1,129 | 456 | 591 | 459 | 395 | 352 | 310 | 286 | 256 | 240 | 233 | 246 | 258 | 264 | 198 | 217 | 131 | 141 | 152 |
Cash Equivalents | -13.8% | 283 | 328 | 498 | 141 | 281 | 157 | 128 | 100 | 66.00 | 91.00 | 93.00 | 86.00 | 58.00 | 52.00 | 215 | 218 | 123 | 140 | 39.00 | 42.00 | 138 |
Inventory | 3.4% | 111 | 108 | 97.00 | 92.00 | 83.00 | 75.00 | 69.00 | 60.00 | 53.00 | 43.00 | 39.00 | 36.00 | 34.00 | 30.00 | 29.00 | 23.00 | 16.00 | 12.00 | 9.00 | 8.00 | 7.00 |
Net PPE | 14.2% | 79.00 | 69.00 | 62.00 | 60.00 | 54.00 | 48.00 | 39.00 | 32.00 | 28.00 | 24.00 | 23.00 | 21.00 | 20.00 | 16.00 | 13.00 | 13.00 | 13.00 | 5.00 | 4.00 | 3.00 | 3.00 |
Goodwill | 0% | 40.00 | 40.00 | 40.00 | 40.00 | 40.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Liabilities | -0.7% | 892 | 898 | 873 | 170 | 213 | 135 | 120 | 112 | 105 | 104 | 79.00 | 68.00 | 65.00 | 46.00 | 44.00 | 42.00 | 43.00 | 39.00 | 30.00 | 27.00 | 28.00 |
Current Liabilities | -11.4% | 92.00 | 104 | 78.00 | 80.00 | 142 | 63.00 | 54.00 | 66.00 | 51.00 | 52.00 | 40.00 | 36.00 | 33.00 | 26.00 | 21.00 | 18.00 | 19.00 | 24.00 | 19.00 | 15.00 | 15.00 |
Long Term Debt | 0.1% | 733 | 732 | 731 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
LT Debt, Current | - | - | - | - | - | - | - | - | - | - | 6.00 | - | - | - | - | - | - | - | - | - | - | - |
LT Debt, Non Current | -100.0% | - | 732 | 731 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shareholder's Equity | 12.4% | 752 | 669 | 601 | 617 | 571 | 511 | 356 | 305 | 268 | 242 | 220 | 208 | 204 | 226 | 237 | 245 | 178 | 193 | 108 | 119 | 129 |
Retained Earnings | 50.1% | 166 | 110 | 66.00 | 31.00 | 2.00 | -36.81 | -177 | -212 | -238 | -252 | -265 | -267 | -267 | -243 | -227 | -214 | -196 | -177 | -163 | -150 | -139 |
Additional Paid-In Capital | 5.0% | 586 | 558 | 535 | 586 | 569 | 549 | 535 | 519 | 507 | 495 | 486 | 476 | 471 | 469 | 465 | 460 | 374 | 371 | 271 | 270 | 269 |
Shares Outstanding | 0.8% | 37.00 | 37.00 | 37.00 | 37.00 | 36.00 | 36.00 | 36.00 | 36.00 | 36.00 | 35.00 | - | 34,914 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 7,700 | - | - | - | - | - | - | - | 3,700 | - | - | - | 4,200 | - | - | - | 1,000 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -50.0% | 35,840 | 71,703 | 50,651 | 39,737 | 33,962 | 52,436 | 34,488 | 28,871 | 1,937 | 20,831 | 9,322 | 2,186 | -17,303 | -12,399 | -16,430 | -18,166 | -24,189 | -12,570 | -10,604 | -10,518 | -14,415 |
Share Based Compensation | 5.2% | 22,937 | 21,811 | 18,410 | 17,046 | 15,967 | 12,643 | 11,732 | 11,005 | 9,510 | 8,208 | 7,387 | 6,523 | 5,139 | 3,242 | 2,846 | 2,391 | 1,871 | 1,310 | 1,106 | 818 | 412 |
Cashflow From Investing | 65.1% | -84,453 | -242,262 | -305,879 | -83,768 | 6,182 | -35,276 | -5,276 | 5,816 | -27,414 | -23,102 | -4,782 | 27,214 | 27,086 | -153,607 | 12,106 | 29,703 | 4,325 | 16,791 | 7,641 | -83,555 | -420 |
Cashflow From Financing | 3155.5% | 5,011 | -164 | 612,997 | -95,841 | 83,409 | 9,596 | 383 | 500 | 2,520 | 500 | 2,387 | -2,138 | -3,200 | 1,173 | 1,284 | 83,648 | 3,930 | 96,372 | 491 | -2,067 | 113,256 |
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Revenue: | ||
Product revenue | $ 218,805 | $ 161,066 |
Cost of revenue: | ||
Cost of product revenue | 28,207 | 21,066 |
Gross profit | 190,598 | 140,000 |
Operating expenses: | ||
Research and development | 44,466 | 26,971 |
Sales and marketing | 74,492 | 54,011 |
General and administrative | 29,233 | 19,204 |
Total operating expenses | 148,191 | 100,186 |
Income from operations | 42,407 | 39,814 |
Income (loss) from equity method investment | 713 | (823) |
Interest and Other Income | 12,318 | 1,740 |
Interest expense | (2,943) | (636) |
Other (expense) income, net | (2,496) | 642 |
Net income before taxes | 49,999 | 40,737 |
Income tax expense | (5,347) | 1,612 |
Net income | 55,346 | 39,125 |
Other comprehensive income (loss): | ||
Unrealized (loss) gain on available-for-sale securities, net of tax | (402) | 505 |
Net gain reclassified from accumulated other comprehensive income | 0 | (5) |
Total comprehensive income | $ 54,944 | $ 39,625 |
Net income per share | ||
Basic (USD per share) | $ 1.48 | $ 1.07 |
Diluted (USD per share) | $ 1.44 | $ 1.03 |
Denominator: | ||
Basic (in shares) | 37,284,946 | 36,427,263 |
Diluted (in shares) | 38,472,013 | 37,979,448 |
Type of Revenue [Extensible List] | Product [Member] | Product [Member] |
Type of Cost, Good Or Service [Extensible List] | Product [Member] | Product [Member] |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
CURRENT ASSETS: | ||
Cash and cash equivalents | $ 281,674 | $ 328,422 |
Short-term investments | 747,559 | 662,132 |
Accounts receivable, net | 124,440 | 114,552 |
Inventory | 111,215 | 107,587 |
Prepaid expenses and other current assets | 10,462 | 12,567 |
Total current assets | 1,275,350 | 1,225,260 |
Operating lease right-of-use assets | 34,919 | 29,707 |
Property and equipment, net | 78,693 | 68,923 |
Equity method investment | 2,356 | 1,643 |
Intangible assets, net | 91,960 | 92,857 |
Goodwill | 39,568 | 39,568 |
Deferred tax assets | 111,900 | 99,169 |
Other assets | 9,001 | 9,436 |
TOTAL ASSETS | 1,643,747 | 1,566,563 |
CURRENT LIABILITIES: | ||
Accounts payable | 9,843 | 8,868 |
Accrued liabilities | 78,838 | 91,696 |
Lease liability, current portion | 3,653 | 3,641 |
Total current liabilities | 92,334 | 104,205 |
Lease liability, noncurrent portion | 40,336 | 35,103 |
Convertible Debt, Noncurrent | 732,810 | 731,863 |
Related party contract liability, noncurrent portion | 12,273 | 12,273 |
Deferred tax liabilities | 3,609 | 3,609 |
Other liabilities | 7,659 | 9,307 |
TOTAL LIABILITIES | 891,990 | 897,886 |
STOCKHOLDERS’ EQUITY: | ||
Preferred stock | 0 | 0 |
Common stock | 38 | 37 |
Additional paid-in capital | 586,017 | 557,882 |
Accumulated other comprehensive (loss) income | (109) | 293 |
Retained earnings | 165,811 | 110,465 |
TOTAL STOCKHOLDERS’ EQUITY | 751,757 | 668,677 |
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | 1,643,747 | 1,566,563 |
Long-Term Income Tax Liability | $ 2,969 | $ 1,526 |